Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11523175 | 1.00 | FAAH (0.51) | FAAHEPHX2ZDHHC20ZDHHC2EPHX1 | |
| SCHEMBL11596878 | 1.00 | FAAH (0.51) | FAAHEPHX2ZDHHC20ZDHHC2EPHX1 | |
| SCHEMBL11244943 | 1.00 | FAAH (0.51) | FAAHEPHX2ZDHHC20ZDHHC2EPHX1 | |
| SCHEMBL5443617 | 1.00 | FAAH (0.51) | FAAHEPHX2ZDHHC20ZDHHC2EPHX1 | |
| SCHEMBL11594801 | 1.00 | FAAH (0.51) | FAAHEPHX2ZDHHC20ZDHHC2EPHX1 | |
| SCHEMBL11595342 | 1.00 | FAAH (0.51) | FAAHEPHX2ZDHHC20ZDHHC2EPHX1 | |
| SCHEMBL7973521 | 0.98 | FAAH (0.49) | FAAHEPHX2ZDHHC20ZDHHC2EPHX1 | |
| SCHEMBL11336151 | 0.92 | FAAH (0.46) | FAAHEPHX2GAAALDH1A1MAPT | |
| SCHEMBL11326200 | 0.85 | TSHR (0.59) | EPHX2ZDHHC20ZDHHC2EPHX1KDM4E | |
| SCHEMBL13343232 | 0.84 | ALDH1A1 (0.46) | FAAHGAAALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4097605-A | Alkyl thiourea miticides | STAUFFER CHEMICAL COMPANY (US) | 1978-06-27 | — | — | US | claimed |
| US-10253256-B2 | Use of sulfur and selenium compounds as precursors to nanostructured materials | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2019-04-09 | — | — | US | disclosed |
| US-20160237345-A1 | USE OF SULFUR AND SELENIUM COMPOUNDS AS PRECURSORS TO NANOSTRUCTURED MATERIALS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2016-08-18 | — | — | US | disclosed |
| EP-3049370-A1 | USE OF SULFUR AND SELENIUM COMPOUNDS AS PRECURSORS TO NANOSTRUCTURED MATERIALS | The Trustees of Columbia University in the City of New York (US) | 2016-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10253256-B2 | Use of sulfur and selenium compounds as precursors to nanostructured materials | SCLY, TST, SOD1 | FAAH 4020/4885EPHX2 2526/4885ZDHHC20 4104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.